Resources Axios Lunch with SAMS Director David Sanders Press Releases SAMS Formally Endorses Two New Pieces of Legislation to Mitigate Future Drugs Shortages, Secure Pharmaceutical Supply Chain Member's Corner An Urgent Call to Revive the U.S. Pharmaceuticals Supply Chain Press Releases SAMS Urges Congress and Administration to Address Drug Shortage Crisis in Must Pass Pandemic and All-Hazards Preparedness Act (PAHPA) Statements SAMS Applauds Senate Majority Whip Durbin for Highlighting Cancer Drug Shortages Press Releases Securing America’s Medicines and Supply (SAMS) Calls for Construction Authorities to be Included in Pandemic Preparedness Reauthorization Bill Press Releases SAMS Commends Congress for Finally Recognizing Importance of American-made Supply Chain Issues Press Releases SAMS Member US Biologic Receives USDA Conditional Licensure for Novel Oral Vaccine Press Releases SAMS Statement of Support for the Reintroduction of the MADE in America Act Press Releases SAMS Applauds Launch of Bipartisan Domestic Pharmaceutical Manufacturing Caucus Press Releases SAMS Advocates to Boost Prescription Drugs in Shortage Press Releases SAMS Statement on the Establishment of the Select Committee on the Strategic Competition Between the U.S. and the CCP Press Releases SAMS Statement on Passage of The Consolidated Appropriations Act of 2023 Resources Op-Ed: To protect the medical supply chain, ‘made in America’ will be key Press Releases SAMS Statement on Shortages of Critical Medicines in the United States Resources New Study Finds U.S. Manufacturers Operating at Half Capacity Press Releases SAMS Comments on Shortages of Flu-fighting Pharmaceuticals Press Releases SAMS Applauds the Appointment of Livia Shmavonian as the Director of the White House ‘Made in America’ Office Press Releases SAMS Response to the Biden Administration’s $2 Billion Investment in Biomanufacturing Statements SAMS Response to National Biotechnology and Biomanufacturing Initiative